Form 4: Oscar Health CTO Sells Shares After Option Exercise

Oscar Health's President of Technology & CTO, Mario Schlosser, exercised stock options and sold a portion of Class A common stock to cover exercise costs and tax obligations.

Summary

• Mario Schlosser, President of Technology & CTO and Director of Oscar Health, Inc., reported transactions on September 22, 2025.
• He exercised 555,165 stock options with an exercise price of $6.36 per share, which were fully vested and expire on December 7, 2025.
• Concurrently, he converted 395,000 shares of Class B common stock into Class A common stock.
• Following the conversion, he sold 395,000 shares of Class A common stock at a weighted average price of $18.43 per share, with prices ranging from $18.25 to $18.78.
• The sale was conducted to cover the cost of the option exercise and to satisfy tax withholding obligations.
• After these transactions, Mr. Schlosser directly beneficially owns 501,148 shares of Class A Common Stock and 1,515,303 shares of Class B Common Stock.
• He also indirectly beneficially owns 1,399,999 shares of Class B Common Stock through three family trusts, disclaiming beneficial ownership except for his pecuniary interest.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While an insider sale can sometimes be perceived negatively, the stated reason for the sale (to cover exercise costs and tax obligations) is a common and routine practice for executives realizing value from equity compensation. The exercise of options itself can be seen as a positive, indicating the executive is monetizing vested equity.

Positives

• The exercise of stock options indicates that the executive is realizing value from previously granted equity, suggesting a belief in the company's long-term potential when the options were granted.
• The sale price of $18.43 per share is significantly higher than the option exercise price of $6.36, indicating a substantial gain for the executive on the exercised options.

Negatives

• The sale of 395,000 shares by a key executive, even for tax purposes, could be perceived negatively by some investors as it reduces their direct equity stake in the company.

Risks

• No specific risks are mentioned in this Form 4 filing beyond the general market perception of insider sales.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• The sale was effected to cover the cost of exercise and to satisfy the Reporting Person's tax withholding obligation arising from the stock option exercise.

Industry Context

Insider transactions, particularly those involving option exercises and subsequent sales for tax purposes, are common in the technology and healthcare sectors, where executive compensation often includes significant equity components. These transactions are typically routine and part of an executive's long-term compensation realization strategy.

Comparison to Industry Standards

• This is a standard Form 4 filing reporting an insider transaction. The practice of exercising stock options and selling a portion of the acquired shares to cover exercise costs and tax obligations is a common and routine event for executives across various industries, aligning with typical executive compensation realization strategies.

Related Party Transactions

• Mr. Schlosser indirectly beneficially owns 1,399,999 shares of Class B Common Stock through the Noah Pizzo-Schlosser Dynasty Trust, Pizzo-Schlosser Family Dynasty Trust, and Siena Pizzo-Schlosser Dynasty Trust. He disclaims beneficial ownership over these shares except to the extent of his pecuniary interest therein.

Stakeholder Impact

• Shareholders may note the reduction in direct equity ownership by a key executive, although the stated reason for the sale (tax and exercise costs) is a common and generally accepted practice.

Next Steps

• No specific future actions, events, or milestones for the company are mentioned in this filing.

Key Dates

Recommendation

The filing details a routine insider transaction where a key executive exercised stock options and sold shares to cover the costs and tax obligations. This is a common practice and does not inherently signal a change in the company's fundamentals or the executive's long-term confidence. While any insider sale can draw attention, the context suggests it's part of a planned compensation realization rather than a bearish outlook. Therefore, a 'hold' recommendation is appropriate as this single transaction does not provide sufficient new information to alter a fundamental investment thesis.

Keywords

Oscar Health, OSCR, insider trading, Form 4, stock options, share sale, executive compensation, beneficial ownership